The global Swine Healthcare Market size is projected to reach USD 2519 million by 2026, from USD 1932.6 million in 2020, at a CAGR of 4.7% during 2020-2026.
Major Players in the market Elanco (Eli Lilly), Boehringer ingelheim, Zoestis, Virbac, Merck Animal Health, Vetoquinol and Ceva Sante Animale.
Elanco Animal Health Incorporated August 2020 announced it has closed the acquisition of Bayer Animal Health. The transaction, valued at $6.89 billion, expands Elanco’s scale and capabilities, positioning the company for the long term as a leader in the attractive, durable animal health industry. Elanco Future innovation Animal Health Incorporated announced it has closed the acquisition of Bayer Animal Health. The transaction, valued at $6.89 billion, expands Elanco’s scale and capabilities, positioning the company for the long term as a leader in the attractive, durable animal health industry.
The swine health Information center and American association of Swine Veterinarians are sponsoring another in a series of industry chatter-inspired webinars on Oct 2020. A wholistic investigation including timely sampling and appropriate tissues being submitted to the veterinary diagnostic laboratory is needed. During the webinar, presenter will review possibilities, protocols and their experiences dealing with lameness in swine herds, answer questions from participant’s and provide insights for producers dealing with lameness issues.
Two new PCR tests have been added to the swine Health Information Center. A highly sensitive and specific RT-PcR for detecting Porcine Sapovirus genotype III for neonatal diarrhea investigation and a single-tube triplex real –time PCR assay for differential detection of variant strains of pseudorabies virus, including the Chinese high path strain, gives diagnosticians previously unavailable valuable tools. Each is now available to all veterinary diagnostic labs for use and fits SHIC’s mission to make sure the US industry is prepared for emerging disease. The government on Oct 2020 unveiled a new indigenously developed vaccine for controlling classical swine fever, which is a highly contagious fatal pig disease. The new vaccine, developed by Uttar Pradesh-based ICAR-Indian Veterinary Research Institute, will be much cheaper than the existing one. It would cost only Rs 2 per dose compared to the current vaccine's rate of Rs 15-20 per dose and imported Korean vaccine rate of Rs 30 per dose.
Swine health market is segmented based on diseases, route of administration, and geography. Based on diseases, the market is divided into aujeszkys disease (AD), classical swine fever (CSF), actinobacillus pleuropneumonia, mycoplasma hyopneumoniae, swine enteric coronavirus disease, porcine reproductive and respiratory syndrome (PRRS), and salmonella. Based on route of administration, the market is classified into injectable and oral. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is expected to dominate the market due to the rising incidence of swine infections such as swine enteric coronavirus diseases (SECD), porcine epidemic diarrhea (PEDv) and porcine delta coronavirus (PDCoV).